0001104659-23-094815.txt : 20230824 0001104659-23-094815.hdr.sgml : 20230824 20230824121401 ACCESSION NUMBER: 0001104659-23-094815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230824 DATE AS OF CHANGE: 20230824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Javitt Jonathan C CENTRAL INDEX KEY: 0001303782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38302 FILM NUMBER: 231200594 MAIL ADDRESS: STREET 1: 1201 NORTH MARKET STREET STREET 2: SUITE 111 CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001719406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822844431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 484-254-6134 MAIL ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp. DATE OF NAME CHANGE: 20171012 4 1 tm2324394-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-23 0 0001719406 NRX Pharmaceuticals, Inc. NRXP 0001303782 Javitt Jonathan C C/O NRX PHARMACEUTICALS INC 1201 N. MARKET STREET, SUITE 111 WILMINGTON DE 19801 1 1 1 0 Chief Scientist 0 Common Stock 2023-08-23 4 P 0 100000 0.33 A 446332 D Common Stock 12599997 I By the Jonathan Javitt Living Trust Common Stock 1422000 I By the Javitt 2012 Irrevocable Dynasty Trust Common Stock 300000 I By the Jonathan Javitt Donor Advised Fund Held by the Jonathan Javitt Living Trust of which the reporting person is the trustee of such trust. Held by the Javitt 2012 Irrevocable Dynasty Trust of which the reporting person is the grantor of such trust. The reporting person is not a trustee or beneficiary of the Trust, and no beneficiary of the Trust resides in the reporting person's household. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Held by the Jonathan Javitt Donor Advised Fund of which the reporting person is the primary advisor of such fund. /s/ Jonathan C. Javitt 2023-08-24